Recalibration of the limiting antigen avidity EIA to determine mean duration of recent infection in divergent HIV-1 subtypes

PLoS ONE

Volumn 10, Issue 2, 2015, Pages

  Duong, Yen T ^a   Kassanjee, Reshma ^b,c   Welte, Alex ^b   Morgan, Meade ^a   De, Anindya ^a   Dobbs, Trudy ^a   Rottinghaus, Erin ^a   Nkengasong, John ^a   Curlin, Marcel E ^d   Kittinunvorakoon, Chonticha ^d   Raengsakulrach, Boonyos ^d   Martin, Michael ^d   Choopanya, Kachit ^d   Vanichseni, Suphak ^d   Jiang, Yan ^e   Qiu, Maofeng ^e   Yu, Haiying ^e   Hao, Yan ^e   Shah, Neha ^f   Le, Linh Vi ^g   Kim, Andrea A ^h   Nguyen, Tuan Anh ⁱ   Ampofo, William ^j   Parekh, Bharat S ^a   more..

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b STELLENBOSCH UNIVERSITY   (South Africa)

^c UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^d MINISTRY OF PUBLIC HEALTH   (Thailand)

^e CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^f CALIFORNIA DEPARTMENT OF PUBLIC HEALTH   (United States)

^g CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^h Centers for Disease Control and Prevention Kenya   (Kenya)

ⁱ National Institute of Hygiene and Epidemiology   (Viet Nam)

^j University of Ghana   (Ghana)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN;

ACCURACY; ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANALYTICAL PARAMETERS; ANTIGEN BINDING; CONTROLLED STUDY; DISEASE DURATION; ENZYME IMMUNOASSAY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; LIMITING ANTIGEN VIDITY; MAJOR CLINICAL STUDY; MEAN DURATION OF RECENT INFECTION; PROPORTION FALSE RECENT; REVIEW; SEROCONVERSION; STATISTICAL ANALYSIS; ANTIBODY AFFINITY; CALIBRATION; CLASSIFICATION; GENETICS; HIV SEROPOSITIVITY; IMMUNOLOGY; SEROLOGY; STANDARDS;

HUMAN IMMUNODEFICIENCY VIRUS 1;

ANTIBODY AFFINITY; CALIBRATION; HIV ANTIGENS; HIV SEROPOSITIVITY; HIV-1; HUMANS; IMMUNOENZYME TECHNIQUES; SEROLOGIC TESTS;

EID: 84923375319     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0114947     Document Type: Review

References (60)

1. Parekh BS, Hu DJ, Vanichseni S, Satten GA, Candal D, et al. (2001) Evaluation of a sensitive/less-sensitive testing algorithm using the 3A11-LS assay for detecting recent HIV seroconversion, among individuals with HIV-1 subtype B or E infection in Thailand. AIDS Research & Human Retroviruses 17: 453-458. doi: 10.1371/journal.pmed.1001777 PMID: 25590520
2. Parekh BS, Pau CP, Kennedy MS, Dobbs TL, McDougal JS (2001) Assessment of antibody assays for identifying and distinguishing recent from long-term HIV type 1 infection. AIDS Research & Human Retroviruses 17: 137-146. doi: 10.1371/journal.pmed.1001777 PMID: 25590520
3. Parekh BS, Kennedy MS, Dobbs T, Pau CP, Byers R, et al. (2002) Quantitative detection of increasing HIV type 1 antibodies after seroconversion: a simple assay for detecting recent HIV infection and estimating incidence. AIDS Research & Human Retroviruses 18: 295-307. doi: 10.1371/journal.pmed.1001777 PMID: 25590520
4. Parekh BS, McDougal JS (2005) Application of laboratory methods for estimation of HIV-1 incidence. Indian Journal of Medical Research 121: 510-518. PMID: 15817960
5. Wei X, Liu X, Dobbs T, Kuehl D, Nkengasong JN, et al. (2010) Development of Two Avidity Based Assays to Detect Recent HIV-1 Seroconversion Using a Multi-subtype gp41 Recombinant Protein. AIDS Research & Human Retroviruses 26: 61-71. doi: 10.1371/journal.pmed.1001777 PMID: 25590520
6. Duong YT, Qiu M, De AK, Jackson K, Dobbs T, et al. (2012) Detection of Recent HIV-1 Infection Using a New Limiting-Antigen Avidity Assay: Potential for HIV-1 Incidence Estimates and Avidity Maturation Studies. PLoS One 7: e33328. doi: 10.1371/journal.pone.0033328 PMID: 22479384
7. Granade TC, Nguyen S, Kuehl DS, Parekh BS (2013) Development of a novel rapid HIV test for simultaneous detection of recent or long-term HIV type 1 infection using a single testing device. AIDS Res Hum Retroviruses 29: 61-67. doi: 10.1089/aid.2012.0121 PMID: 23281586
8. Soroka SD, Granade TC, Candal D, Parekh BS (2005) Modification of rapid human immunodeficiency virus (HIV) antibody assay protocols for detecting recent HIV seroconversion. Clinical & Diagnostic Laboratory Immunology 12: 918-921. doi: 10.1038/srep07632 PMID: 25591183
9. Janssen RS, Satten GA, Stramer SL, Rawal BD, O'Brien TR, et al. (1998) New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. [erratum appears in JAMA 1999 May 26;281(20):1893]. JAMA 280: 42-48. PMID: 9660362
10. Kothe D, Byers RH, Caudill SP, Satten GA, Janssen RS, et al. (2003) Performance characteristics of a new less sensitive HIV-1 enzyme immunoassay for use in estimating HIV seroincidence. Journal of Acquired Immune Deficiency Syndromes: JAIDS 33: 625-634. PMID: 12902808
11. Barin F, Meyer L, Lancar R, Deveau C, Gharib M, et al. (2005) Development and validation of an immunoassay for identification of recent human immunodeficiency virus type 1 infections and its use on dried serum spots. Journal of Clinical Microbiology 43: 4441-4447. PMID: 16145089
12. Suligoi B, Galli C, Massi M, Di Sora F, Sciandra M, et al. (2002) Precision and accuracy of a procedure for detecting recent human immunodeficiency virus infections by calculating the antibody avidity index by an automated immunoassay-based method. Journal of Clinical Microbiology 40: 4015-4020. PMID: 12409368
13. Suligoi B, Massi M, Galli C, Sciandra M, Di Sora F, et al. (2003) Identifying recent HIV infections using the avidity index and an automated enzyme immunoassay. Journal of Acquired Immune Deficiency Syndromes: JAIDS 32: 424-428. PMID: 12640201
14. Suligoi B, Rodella A, Raimondo M, Regine V, Terlenghi L, et al. (2011) Avidity Index for anti-HIV antibodies: comparison between third- and fourth-generation automated immunoassays. J Clin Microbiol 49: 2610-2613. doi: 10.1128/JCM.02115-10 PMID: 21543577
15. Wilson KM, Johnson EI, Croom HA, Richards KM, Doughty L, et al. (2004) Incidence immunoassay for distinguishing recent from established HIV-1 infection in therapy-naive populations. AIDS 18: 2253-2259. PMID: 15577537
16. Constantine NT, Sill AM, Jack N, Kreisel K, Edwards J, et al. (2003) Improved classification of recent HIV-1 infection by employing a two-stage sensitive/less-sensitive test strategy. Journal of Acquired Immune Deficiency Syndromes: JAIDS 32: 94-103. PMID: 12514420
17. Li H, Ketema F, Sill AM, Kreisel KM, Cleghorn FR, et al. (2007) A simple and inexpensive particle agglutination test to distinguish recent from established HIV-1 infection. International Journal of Infectious Diseases 11: 459-465. PMID: 17369067
18. Sill AM, Kreisel K, Deeds BG, Wilson CM, Constantine NT, et al. (2007) Calibration and validation of an oral fluid-based sensitive/less-sensitive assay to distinguish recent from established HIV-1 infections. Journal of Clinical Laboratory Analysis 21: 40-45. PMID: 17245763
19. Hargrove JW, Humphrey JH, Mutasa K, Parekh BS, McDougal JS, et al. (2008) Improved HIV-1 incidence estimates using the BED capture enzyme immunoassay. AIDS 22: 511-518. doi: 10.1097/QAD.0b013e3282f2a960 PMID: 18301064
20. Kim AA, McDougal JS, Hargrove J, Rehle T, Pillay-Van Wyk V, et al. (2010) Evaluating the BED capture enzyme immunoassay to estimate HIV incidence among adults in three countries in sub-Saharan Africa. AIDS Res Hum Retroviruses 26: 1051-1061. doi: 10.1089/aid.2009.0218 PMID: 20849299
21. Parekh BS, Hanson DL, Hargrove J, Branson B, Green T, et al. (2011) Determination of mean recency period for estimation of HIV type 1 Incidence with the BED-capture EIA in persons infected with diverse subtypes. AIDS Res Hum Retroviruses 27: 265-273. doi: 10.1089/aid.2010.0159 PMID: 20954834
22. Guy R, Gold J, Calleja JMG, Kim AA, Parekh B, et al. (2009) Accuracy of serological assays for detection of recent infection with HIV and estimation of population incidence: a systematic review. The Lancet Infectious Diseases 9: 747-759. doi: 10.1016/S1473-3099(09)70300-7 PMID: 19926035
23. Young CL, Hu DJ, Byers R, Vanichseni S, Young NL, et al. (2003) Evaluation of a sensitive/less sensitive testing algorithm using the bioMerieux Vironostika-LS assay for detecting recent HIV-1 subtype B' or E infection in Thailand. AIDS Research & Human Retroviruses 19: 481-486. doi: 10.1371/journal. pmed.1001777 PMID: 25590520
24. Barnighausen T, McWalter TA, Rosner Z, Newell ML, Welte A (2010) HIV incidence estimation using the BED capture enzyme immunoassay: systematic review and sensitivity analysis. Epidemiology 21: 685-697. doi: 10.1097/EDE.0b013e3181e9e978 PMID: 20699682
25. Hallett TB, Ghys P, Barnighausen T, Yan P, Garnett GP (2009) Errors in 'BED'-derived estimates of HIV incidence will vary by place, time and age. PLoS ONE [Electronic Resource] 4: e5720. doi: 10. 1371/journal.pone.0005720 PMID: 19479050
26. McDougal JS, Pilcher CD, Parekh BS, Gershy-Damet G, Branson BM, et al. (2005) Surveillance for HIV-1 incidence using tests for recent infection in resource-constrained countries. AIDS 19 Suppl 2: S25-30. PMID: 15930838
27. Busch MP, Pilcher CD, Mastro TD, Kaldor J, Vercauteren G, et al. (2010) Beyond detuning: 10 years of progress and new challenges in the development and application of assays for HIV incidence estimation. AIDS 24: 2763-2771. doi: 10.1097/QAD.0b013e32833f1142 PMID: 20975514
28. Mastro TD, Kim AA, Hallett T, Rehle T, Welte A, et al. (2010) Estimating HIV Incidence in Populations Using Tests for Recent Infection: Issues, Challenges and the Way Forward. J HIV AIDS Surveill Epidemiol 2: 1-14. PMID: 21743821
29. Mastro TD (2013) Determining HIV incidence in populations: moving in the right direction. J Infect Dis 207: 204-206. doi: 10.1093/infdis/jis661 PMID: 23129757
30. Smolen-Dzirba J, Wasik TJ (2011) Current and future assays for identifying recent HIV infections at the population level. Med Sci Monit 17: RA124-133. PMID: 21525823
31. Welte A, McWalter TA, Laeyendecker O, Hallett TB (2010) Using tests for recent infection to estimate incidence: problems and prospects for HIV. Euro Surveill 15.
32. Hladik W, Musinguzi J, Kirungi W, Opio A, Stover J, et al. (2008) The estimated burden of HIV/AIDS in Uganda, 2005- 2010. AIDS 22: 503-510. doi: 10.1097/QAD.0b013e3282f470be PMID: 18301063
33. Kim AA, Hallett T, Stover J, Gouws E, Musinguzi J, et al. (2011) Estimating HIV incidence among adults in Kenya and Uganda: a systematic comparison of multiple methods. PLoS ONE 6: e17535. doi: 10. 1371/journal.pone.0017535 PMID: 21408182
34. Heimer R (2008) Community coverage and HIV prevention: assessing metrics for estimating HIV incidence through syringe exchange. International Journal of Drug Policy 19 Suppl 1: S65-73. doi: 10. 1016/j.drugpo.2007.12.004 PMID: 18207726
35. Brown T, Bao L, Raftery AE, Salomon JA, Baggaley RF, et al. (2010) Modelling HIV epidemics in the antiretroviral era: the UNAIDS Estimation and Projection package 2009. Sex Transm Infect 86 Suppl 2: ii3-10. doi: 10.1136/sti.2010.044784 PMID: 20929855
36. UNAIDS (2010) UNAIDS Report on the global AIDS epidemic 2010. Joint United Nations Programme on HIV/AIDS (UNAIDS).
37. Hallett TB, Zaba B, Todd J, Lopman B, Mwita W, et al. (2008) Estimating incidence from prevalence in generalised HIV epidemics: methods and validation. PLoS Medicine / Public Library of Science 5: e80.
38. Hallett TB, Singh K, Smith JA, White RG, Abu-Raddad LJ, et al. (2008) Understanding the impact of male circumcision interventions on the spread of HIV in southern Africa. PLoS ONE [Electronic Resource] 3: e2212. doi: 10.1371/journal.pone.0002212 PMID: 18493593
39. Hoare A, Wilson DP, Regan DG, Kaldor J, Law MG (2008) Using mathematical modelling to help explain the differential increase in HIV incidence in New South Wales, Victoria and Queensland: importance of other sexually transmissible infections. Sexual Health 5: 169-187. PMID: 18686336
40. Walker PT, Hallett TB, White PJ, Garnett GP (2008) Interpreting declines in HIV prevalence: impact of spatial aggregation and migration on expected declines in prevalence. Sexually Transmitted Infections 84 Suppl 2: ii42-48. doi: 10.1136/sti.2008.029975 PMID: 18799492
41. Wilson DP, Hoare A, Regan DG, Law MG (2009) Importance of promoting HIV testing for preventing secondary transmissions: modelling the Australian HIV epidemic among men who have sex with men. Sexual Health 6: 19-33. PMID: 19254488
42. Chemaitelly H, Abu-Raddad LJ (2013) External infections contribute minimally to HIV incidence among HIV sero-discordant couples in sub-Saharan Africa. Sex Transm Infect 89: 138-141. doi: 10.1136/sextrans-2012-050651 PMID: 22930346
43. Andersson E, Shao W, Bontell I, Cham F, Cuong DD, et al. (2013) Evaluation of sequence ambiguities of the HIV-1 pol gene as a method to identify recent HIV-1 infection in transmitted drug resistance surveys. Infect Genet Evol 18C: 125-131.
44. Curtis KA, Kennedy MS, Charurat M, Nasidi A, Delaney K, et al. (2012) Development and Characterization of a Bead-Based, Multiplex Assay for Estimation of Recent HIV Type 1 Infection. AIDS Res Hum Retroviruses 28: 188-197. doi: 10.1089/AID.2011.0037 PMID: 21585287
45. Sharma UK, Schito M, Welte A, Rousseau C, Fitzgibbon J, et al. (2012) Workshop Summary: Novel Biomarkers for HIV Incidence Assay Development. AIDS Res Hum Retroviruses.
46. Ragonnet-Cronin M, Aris-Brosou S, Joanisse I, Merks H, Vallee D, et al. (2012) Genetic diversity as a marker for timing infection in HIV-infected patients: evaluation of a 6-month window and comparison with BED. J Infect Dis 206: 756-764. doi: 10.1093/infdis/jis411 PMID: 22826337
47. Hudgens MG, Longini IM Jr, Vanichseni S, Hu DJ, Kitayaporn D, et al. (2002) Subtype-specific transmission probabilities for human immunodeficiency virus type 1 among injecting drug users in Bangkok, Thailand. American Journal of Epidemiology 155: 159-168. PMID: 11790680
48. van Griensven G, Tielman RA, Goudsmit J, van der Noordaa J, de Wolf F, et al. (1987) Risk factors and prevalence of HIV antibodies in homosexual men in the Netherlands. American J of Epidemiology 125: 1048-1057. PMID: 3495173
49. Ludo L, Baeten JM, Kreiss JK, Richardson BA, Chohan BH, et al. (2004) Injectable contraceptive use and genital ulcer disease during the early phase of HIV-1 infection increase plasma virus load in women. Journal of Infectious Diseases 189: 303-311. PMID: 14722896
50. Smith D, Warren DL, Vlahov D, Schuman P, Stein MD, et al. for the Human Immunodeficiency Virus Epidemiology Research Study Group (1997) Design and baseline participant characteristics of the Human Immunodeficiency Virus Epidemiology Research (HER) Study: a prospective cohort study of human immunodeficiency virus infection in US women. Am J epidemiology 146: 459-469. PMID: 9290506
51. Kassanjee R, McWalter TA, Barnighausen T, Welte A (2012) A new general biomarker-based incidence estimator. Epidemiology 23: 721-728. doi: 10.1097/EDE.0b013e3182576c07 PMID: 22627902
52. Brookmeyer R, Konikoff J, Laeyendecker O, Eshleman SH (2013) Estimation of HIV incidence using multiple biomarkers. Am J Epidemiol 177: 264-272. doi: 10.1093/aje/kws436 PMID: 23302151
53. Efron B, Tibshirani RJ (1993) An Introduction to the Bootstrap: Chapman & Hall/CRC.
54. Ying S, Gordon J, Se HK. Analyzing Interval-Censored Survival Data with SAS Software. In: Inc. SI, editor; 2010; Cary, NC.
55. Hallett TB (2011) Estimating the HIV incidence rate: recent and future developments. Curr Opin HIV AIDS 6: 102-107. doi: 10.1097/COH.0b013e328343bfdb PMID: 21505383
56. Incidence Assay Critical Path Group (2011) More and better information to tackle HIV epidemics: towards improved HIV incidence assays. PLoS Medicine / Public Library of Science 8(6):e1001045. doi: 10.1371/journal.pmed.1001045 PMID: 21731474
57. WHO/UNAIDS (2012) UNAIDS/WHO Working Group on Global HIV/AIDS and STI Surveillance. When and how to use assays for recent infection to estimate HIV incidence at a population level.
58. Sweeting M, Angelis DD, Parry P, and Suligoi B (2010) Estimating the distribution of the window period for recent HIV infections: a comparison of statistical methods. Statistics in Medicine DOI: 10.1002/sim.0000.
59. Laeyendecker O, Brookmeyer R, Cousins MM, Mullis CE, Konikoff J, et al. (2013) HIV incidence determination in the United States: a multiassay approach. J Infect Dis 207: 232-239. doi: 10.1093/infdis/jis659 PMID: 23129760
60. Eshleman SH, Hughes JP, Laeyendecker O, Wang J, Brookmeyer R, et al. (2013) Use of a multifaceted approach to analyze HIV incidence in a cohort study of women in the United States: HIV Prevention Trials Network 064 Study. J Infect Dis 207: 223-231. doi: 10.1093/infdis/jis658 PMID: 23129758